Revenue¥36.8bn+25.5% year on yearConsolidated · FY12/25
Ordinary profit¥2.20bn−46.0% year on yearConsolidated · FY12/25
Net profit¥975m−65.2% year on yearConsolidated · FY12/25
Employees, whole group1,815 peopleFY12/25
Employees, parent company (non-consolidated)1,511 peopleFY12/25
Average salary¥5.63mFY12/25
Average salary is for the parent company's own employees (non-consolidated), as Japanese annual reports disclose it.
| Fiscal year | Revenue | Ordinary profit | Net profit (attributable) | EPS | Total assets | Net assets | Op. cash flow |
|---|---|---|---|---|---|---|---|
| FY12/25 | ¥36.8bn+25.5% year on year | ¥2,202m | ¥975m | ¥30.62 | ¥41.3bn | ¥14.8bn | ¥3.49bn |
| FY12/24 | ¥29.3bn+42.7% year on year | ¥4,078m | ¥2,798m | ¥86.17 | ¥45.2bn | ¥20.2bn | ¥2.45bn |
| FY12/23 | ¥20.5bn+44.7% year on year | ¥3,755m | ¥2,566m | ¥79.53 | ¥25.4bn | ¥17.6bn | ¥3.87bn |
| FY12/22 | ¥14.2bn+30.6% year on year | ¥1,526m | ¥1,017m | ¥31.77 | ¥21.8bn | ¥15.2bn | ¥2.01bn |
| FY12/21 | ¥10.9bn | ¥743m | ¥563m | ¥17.79 | ¥20.2bn | ¥14.0bn | ¥1.04bn |
Per-share figures are as each report states them: a share split is restated only for the year before it, and dividends are as paid.
Figures from annual report S100XUX3 · Japan GAAP. Each figure's years come from one report's five-year summary.
TSE:4480
Medley suspended its @link medical-institution system and patient app on October 14 after confirming unauthorized access; patient data may have leaked from as many as 787 institutions, and no restart date has been given.
Medley's first-half net profit rose 131% to ¥1.5bn on hiring-platform growth, and the healthcare-jobs company also borrowed ¥5bn from two banks and took full ownership of the business behind Recruit Medical Career weeks after the half closed.
Authorised and executed under the company’s current programmes.
The line marks how much of the buying window has passed; a bar beyond it is buying ahead of pace.
| Resolution | Progress by company | Filing |
|---|---|---|
| Runs to 31 Mar 2026 | 100% of yen limit used¥3bn / ¥3bn · 1.39m / 1.5m shares100% of the buying window to 31 Mar 2026 has passed | Filed — filing S100XYOY |
| Runs to 31 Dec 2025 | 94% of yen limit used¥2.85bn / ¥3bn · 1.05m / 1.05m shares100% of the buying window to 31 Dec 2025 has passed | Filed — filing S100XFOA |
Latest disclosed holders and exits below 5%.
| Holder | Stake | Change | Purpose | Filing |
|---|---|---|---|---|
| アセットマネジメントOne株式会社 | 5.06% | New | Asset manager / trust・投資信託または投資一任契約に基づき投資権限を有するもの | Filed — filing S100Z6H7 |
Strategic shareholdings and sales, by fiscal year.
Balance-sheet value is the reporting company's own listed holdings (its largest holding subsidiary's where marked), carried at market value; the percentage divides it by consolidated net assets in the same annual report.
| Fiscal year end | Holdings (issuers) | Balance-sheet value | % of consolidated net assets | Issues cut | Sale proceeds | Filing |
|---|---|---|---|---|---|---|
| 31 Dec 2025 | No listed strategic holdings reported | — | — | — | — | Filed |
| Fiscal year end | Holdings (issuers) | Balance-sheet value | % of consolidated net assets | Issues cut | Sale proceeds | Filing |
|---|---|---|---|---|---|---|
| 31 Dec 2024 | No listed strategic holdings reported | — | — | — | — | Filed |
| 31 Dec 2023 | No listed strategic holdings reported | — | — | — | — | Filed |
| 31 Dec 2022 | No listed strategic holdings reported | — | — | — | — | Filed |
| 31 Dec 2021 | No listed strategic holdings reported | — | — | — | — | Filed |
Current holdings disclosed by tracked funds.
Held by 23 tracked funds; largest weight 1.00%. Holdings as of 31 Jul 2026–11 Nov 2026.
| Fund | NAV weight |
|---|---|
| NZAM ETF TOPIX Ex-Financials | 0.01% |
| iShares Core TOPIX ETF | 0.01% |
| NZAM ETF TOPIX | 0.01% |
| SMDAM TOPIX ETF | 0.00% |
| Listed Index Fund TOPIX **** | 0.00% |
| MAXIS TOPIX ETF | 0.00% |
| iFreeETF TOPIX (Quarterly Dividend Type) **** | 0.00% |
| iFreeETF TOPIX (Yearly Dividend Type) **** | 0.00% |
| One ETF TOPIX | 0.00% |
| Nissay ETF TOPIX (Quarterly settlement type) | 0.00% |
| NEXT FUNDS TOPIX Exchange Traded Fund | 0.00% |
| Listed Index Fund TOPIX Ex-Financials **** | 0.00% |
| The Japanese Small Company Series | 0.00% |